SavedAdd your journal

Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2006 / Cilt: 16 - Sayı: 2

Positron emission tomography imaging in lymphoma

Lenfomalarda pozitron emisyon tomografi görüntülemenin yeri

H. Mehmet TÜRK
M. Emin KALENDER
Pages
108–113
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, 18Ffluorodeoxyglucose positron emission tomography is found to be superior to galyum 67 in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The role of 18F-fluorodeoxyglucose positron emission tomography in the staging of lymphoma, response to treatment and early diagnosis of relapses were evaluated in this review. 18F-fluorodeoxyglucose positron emission tomography is the best noninvasive screening method after treatment.
📊
Key Findings & Data:However, the findings should be correlated with the clinical data, other radiological methods and biopsy. 18F-fluorodeoxyglucose positron emission tomography is superior to conventional radiological methods in the initial evoluation of Hodgkin lymphoma. 18F-fluorodeoxyglucose positron emission tomography when combined with computed tomography has advantages to both of the separate methods. 18F-fluorodeoxyglucose positron emission tomography is also benecial in defining the radiotherapy area and the planning of the surgical biopsy.
💡
Conclusion & Impact:Moreover, 18Ffluorodeoxyglucose positron emission tomography is found to be superior to galyum 67 in the literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Tomografi · emisyon-bilgisayarlı · Florodeoksiglikoz F18

Abstract

The role of 18F-fluorodeoxyglucose positron emission tomography in the staging of lymphoma, response to treatment and early diagnosis of relapses were evaluated in this review. 18F-fluorodeoxyglucose positron emission tomography is the best noninvasive screening method after treatment. However, the findings should be correlated with the clinical data, other radiological methods and biopsy. 18F-fluorodeoxyglucose positron emission tomography is superior to conventional radiological methods in the initial evoluation of Hodgkin lymphoma. 18F-fluorodeoxyglucose positron emission tomography when combined with computed tomography has advantages to both of the separate methods. 18F-fluorodeoxyglucose positron emission tomography is also benecial in defining the radiotherapy area and the planning of the surgical biopsy. Moreover, 18Ffluorodeoxyglucose positron emission tomography is found to be superior to galyum 67 in the literature.

Özet

Bu incelemede 18F-fluorodeoksiglukoz pozitron emisyon tomografinin lenfomaların evrelendirilmesinde, tedaviye yanıtın değerlendirilmesinde ve relapsların erken teşhisindeki rolü hakkında yapılmış olan çalışmalar değerlendirilmiştir. 18F-fluorodeoksiglukoz pozitron emisyon tomografi tedaviden sonra uygulanabilen en iyi noninvasiv görüntüleme yöntemidir. Ancak yinede bu inceleme sonucunda elde edilen bulguların klinik veriler, diğer görüntüleme yöntemleri veya biopsi ile korele edilmesi gerekir. 18F-fluorodeoksiglukoz pozitron emisyon tomografi Hodgkin lenfoma tanısı olan hastaların ilk evrelendirilmesinde konvansiyonel görüntüleme tekniklerine göre ekbilgi sağladığından daha üstün bulunmuştur. 18F-fluorodeoksiglukoz pozitron emisyon tomografinin bilgisayarlı tomografi ile kombine kullanılması bu tekniklerin ayrı ayrı kullanılmasına göre daha fazla avantajlar sağlamaktadır. 18F-fluorodeoksiglukoz pozitron emisyon tomografi radyoterapi alanının belirlenmesi ve cerrahi biopsinin planlanmasında da özellikle yararlı olabilir. Çalışmalarda 18F-fluorodeoksiglukoz pozitron emisyon tomografinin Galyum 67 sintigrafisinden üstün olduğuda gösterilmiştir.

🔖

Cite This Article

TÜRK, H. M., KALENDER, M. E. (2006). Positron emission tomography imaging in lymphoma. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 16 - Sayı: 2, 108–113. https://ajindex.com/articles/323072

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Dobert N, Menzel C, Hamscho N et al. Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphoma. Q J Nucl Med Mol Imaging 48(1):33-8, 2004
  2. Hueltenschmidt B, Sautter-Bihl ML, Lang O et al. Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer 91(2):302-10, 2001
  3. Weihrauch MR, Re D, Bischolff S, Dietlein M et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease. Ann Hematol 81(1):20-5, 2002
  4. Partridge S, Timothy A, O’Doherty MJ et al
  5. Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. Ann Oncol 11(10):1273-9, 2000
  6. Naumann R, Beuthein-Baumann B, Reis A et al. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Br J Cancer 90(3):620-5, 2004
  7. Schoder H, Noy A, Gonen M et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 23(21):4643-51, 2005
  8. Jerusalem G, Beguin Y, Najjar F et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol 12(6):825-30, 2001
  9. Elstrom R, Guan L, Baker G et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 101(10):3875-6, 2003
  10. Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 16(3):473-480, 2005
  11. Wirth A, Seymour JF, Hicks RJ et al. Fluorine- 18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non- Hodgkin's lymphoma. Am J Med 112(4):262-8, 2002 11.Friedberg JW, Fischman A, Neuberg D et al. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: A blinded comparison. Leuk Lymphoma 45(1):85- 92, 2004
  12. Lin P, Chu J, Kneebone A et al. Direct comparison of 18F-fluorodeoxyglucose coincidence gamma camera tomography with gallium scanning for the staging of lymphoma. Intern Med J 35(2):91-6, 2005
  13. Yamamoto F, Tsukamoto E, Nakada K et al. 18F-FDG PET is superior to 67Ga SPECT in the staging of non-Ho